Leiomyosarcoma Clinical Trials in St Louis, Missouri

3 studies are recruiting for leiomyosarcoma in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

    This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri
    Locations
    175 in total
    Run by
    European Organisation for Research and Treatment of Cancer - EORTC

    See if you can join NCT04031677 on ClinicalTrials.gov

  2. NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

    The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free survival for intermediate-risk patients treated with ifosfamide, doxorubicin, pazopanib, surgery, and maintenance pazopanib, with or without RT. * To …

    Stage
    Phase 1
    Ages
    Up to 30
    Site
    Washington University Medical Center, St Louis, Missouri
    Locations
    7 in total
    Run by
    St. Jude Children's Research Hospital

    See if you can join NCT06239272 on ClinicalTrials.gov

  3. Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

    THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study evaluates the safety and efficacy of AL3818 (anlotinib) hydrochloride in the treatment of metastatic or advanced alveolar soft pa…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Washington University St. Louis, St Louis, Missouri
    Locations
    24 in total
    Run by
    Advenchen Laboratories, LLC

    See if you can join NCT03016819 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.